BRPI0909000A2 - Soluções oftálmicas que apresentam eficácia otimizada - Google Patents

Soluções oftálmicas que apresentam eficácia otimizada

Info

Publication number
BRPI0909000A2
BRPI0909000A2 BRPI0909000-2A BRPI0909000A BRPI0909000A2 BR PI0909000 A2 BRPI0909000 A2 BR PI0909000A2 BR PI0909000 A BRPI0909000 A BR PI0909000A BR PI0909000 A2 BRPI0909000 A2 BR PI0909000A2
Authority
BR
Brazil
Prior art keywords
ophthalmic solutions
optimal effectiveness
exhibit optimal
exhibit
effectiveness
Prior art date
Application number
BRPI0909000-2A
Other languages
English (en)
Inventor
Gary L Collins
Frank F Molock Jr
Shivkumar Mahadevan
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of BRPI0909000A2 publication Critical patent/BRPI0909000A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124—Hydrogen peroxide; Peroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A61L12/145—Polymeric quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
BRPI0909000-2A 2008-03-19 2009-03-09 Soluções oftálmicas que apresentam eficácia otimizada BRPI0909000A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3789408P 2008-03-19 2008-03-19
US12/399,662 US20090239775A1 (en) 2008-03-19 2009-03-06 Ophthalmic solutions displaying improved efficacy
PCT/US2009/001496 WO2009117057A1 (en) 2008-03-19 2009-03-09 Ophthalmic solutions displaying improved efficacy

Publications (1)

Publication Number Publication Date
BRPI0909000A2 true BRPI0909000A2 (pt) 2015-08-04

Family

ID=41089519

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0909000-2A BRPI0909000A2 (pt) 2008-03-19 2009-03-09 Soluções oftálmicas que apresentam eficácia otimizada
BRPI0909763A BRPI0909763A2 (pt) 2008-03-19 2009-03-09 soluções oftálmicas tamponadas com fosfato que apresentam eficácia otimizada

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0909763A BRPI0909763A2 (pt) 2008-03-19 2009-03-09 soluções oftálmicas tamponadas com fosfato que apresentam eficácia otimizada

Country Status (12)

Country Link
US (2) US20090239775A1 (pt)
EP (2) EP2271313A1 (pt)
JP (2) JP2011515393A (pt)
KR (2) KR20100126512A (pt)
CN (2) CN101977590A (pt)
AR (2) AR070999A1 (pt)
AU (2) AU2009226113A1 (pt)
BR (2) BRPI0909000A2 (pt)
CA (2) CA2718866A1 (pt)
RU (2) RU2010142488A (pt)
TW (2) TW200950822A (pt)
WO (2) WO2009117057A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
WO2011001461A1 (ja) 2009-06-29 2011-01-06 株式会社メニコン コンタクトレンズの消毒システム
TW201127423A (en) * 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
JP2011251932A (ja) * 2010-06-01 2011-12-15 Mandom Corp 点眼剤及び洗眼剤
TW201340962A (zh) * 2012-02-27 2013-10-16 Rohto Pharma 眼科用組成物
AU2013384818A1 (en) * 2013-03-27 2015-11-12 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
WO2014190141A1 (en) * 2013-05-23 2014-11-27 Stone Ralph P Scleral lens solution
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
TW202014194A (zh) 2018-04-27 2020-04-16 美商歐樂根公司 抗微生物功效增強且毒性降低之亞氯酸鈉組成物
CN114318343A (zh) * 2020-09-29 2022-04-12 上海飞凯材料科技股份有限公司 一种蚀刻液及其应用
WO2024134381A1 (en) * 2022-12-21 2024-06-27 Johnson & Johnson Vision Care, Inc. Compositions for ophthalmologic devices
WO2024134384A1 (en) * 2022-12-21 2024-06-27 Johnson & Johnson Vision Care, Inc. Compositions for ophthalmologic devices
WO2024134382A1 (en) * 2022-12-21 2024-06-27 Johnson & Johnson Vision Care, Inc. Compositions for ophthalmologic devices

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
US5451398A (en) * 1990-01-05 1995-09-19 Allergan, Inc. Ophthalmic and disinfecting compositions and methods for preserving and using same
US5277901A (en) * 1990-01-05 1994-01-11 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5145643A (en) * 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5019380A (en) * 1990-04-27 1991-05-28 Bausch & Lomb Incorporated Novel antimicrobial compositions and process for preparing the same
US5523012A (en) * 1991-07-19 1996-06-04 Ciba-Geigy Corporation Hydrogen peroxide disinfection solutions
DE4132259A1 (de) * 1991-09-27 1993-04-01 Wild Heerbrugg Ag Ueberstrahlungsschutz fuer ein nachtsichtgeraet
US5356555A (en) * 1992-09-14 1994-10-18 Allergan, Inc. Non-oxidative method and composition for simultaneously cleaning and disinfecting contact lenses using a protease with a disinfectant
JPH08504623A (ja) * 1992-12-17 1996-05-21 アラーガン、インコーポレイテッド 亜塩素酸ナトリウムおよびポリビニルピロリドンを含有するコンタクトレンズ消毒溶液
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US5648074A (en) * 1993-05-25 1997-07-15 Allergan Compositions and methods for disinfecting contact lenses and reducing proteinaceous deposit formation
JP2839819B2 (ja) * 1993-05-28 1998-12-16 株式会社東芝 不揮発性半導体記憶装置
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US6024954A (en) * 1994-12-12 2000-02-15 Allergan Compositions and methods for disinfecting contact lenses and preserving contact lens care products
FR2751634B1 (fr) * 1996-07-29 1998-09-11 Essilor Int Solution stabilisee et tamponnee de peroxyde d'hydrogene, son procede de fabrication et son utilisation a la decontamination de lentilles de contact
US5746972A (en) * 1996-11-01 1998-05-05 Allergan Compositions and methods for disinfecting and cleaning contact lenses
DE69923987T2 (de) * 1998-10-08 2006-11-02 Karagoezian, Hampar L., San Juan Capistrano Synergistische antimikrobielle, dermatologische und ophtahalmologische zubereitung, die ein chlorit und wasserstoffperoxid enthalten
US6448062B1 (en) * 1998-10-30 2002-09-10 Metrex Research Corporation Simultaneous cleaning and decontaminating compositions and methods
US6309596B1 (en) * 1998-12-15 2001-10-30 Bausch & Lomb Incorporated Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US20070104798A1 (en) * 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
TWI236377B (en) * 2000-09-28 2005-07-21 Novartis Ag Stabilized hydrogen peroxide solutions
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20050244509A1 (en) * 2004-03-17 2005-11-03 Fu-Pao Tsao Ophthalmic solutions
EP2010143B1 (en) * 2006-03-17 2015-08-12 Johnson & Johnson Vision Care, Inc. Stabilized ophthalmic compositions comprising oxidatively unstable components
US20090004288A1 (en) * 2007-06-29 2009-01-01 Collins Gary L Stabilized ophthalmic solutions

Also Published As

Publication number Publication date
CA2718866A1 (en) 2009-09-24
US20090239954A1 (en) 2009-09-24
AR071001A1 (es) 2010-05-19
RU2010142488A (ru) 2012-04-27
CN101977590A (zh) 2011-02-16
AU2009226113A1 (en) 2009-09-24
EP2271313A1 (en) 2011-01-12
RU2010142462A (ru) 2012-04-27
CN101977591A (zh) 2011-02-16
AR070999A1 (es) 2010-05-19
JP2011515394A (ja) 2011-05-19
KR20100126512A (ko) 2010-12-01
EP2276462A1 (en) 2011-01-26
BRPI0909763A2 (pt) 2015-10-06
TW200950822A (en) 2009-12-16
CA2718864A1 (en) 2009-09-24
JP2011515393A (ja) 2011-05-19
TW201000149A (en) 2010-01-01
AU2009226112A1 (en) 2009-09-24
WO2009117057A1 (en) 2009-09-24
WO2009117056A1 (en) 2009-09-24
KR20100135813A (ko) 2010-12-27
US20090239775A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
NO2018009I2 (no) Dupilumab
NL300879I2 (nl) Alirocumab
BRPI0909000A2 (pt) Soluções oftálmicas que apresentam eficácia otimizada
BRPI0914789A2 (pt) efeitos sinérgicos
BRPI0912271A2 (pt) co-autoria estruturada
BRPI0921327A2 (pt) Combinação de herbicida-protetor
BRPI0907457A2 (pt) Absorventes
DK3444343T3 (da) Polypeptider
BRPI0914649A2 (pt) Piprazolo-quinazolinas
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
FIC20240018I1 (fi) Vamoroloni
DK2335031T3 (da) In-line-måler
BRPI0909488A2 (pt) brocha
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
BRPI0909287A2 (pt) Retenção
BRPI0909634A2 (pt) 2-aminoquinolinas
DE112009000183A5 (de) Sicherheitsvorreiber
BRPI0922728A2 (pt) combinação de herbicida-antídoto
DE602009000488D1 (de) Obstvereinzelvorrichtung
BRPI0909637A2 (pt) 2-aminoquinolinas
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
DE602009000862D1 (de) Gehwagenbremse
AT507449A3 (de) Dämmstoffbefestiger
NO20082318L (no) Bolgeenergigenereringssystem
DK2271864T3 (da) Z-ventil

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.